Display Settings:


Send to:

Choose Destination
See comment in PubMed Commons below
Pediatr Dermatol. 2011 Jan-Feb;28(1):39-45. doi: 10.1111/j.1525-1470.2010.01355.x. Epub 2011 Jan 25.

Hepatic infantile hemangiomas treated with oral propranolol--a case series.

Author information

  • 1Department of Pediatrics, Northwestern University's Feinberg School of Medicine, Chicago, Illinois, USA.


Hepatic infantile hemangiomas may be associated with morbidity and mortality, and traditional therapies may be associated with significant side effects. Since propranolol has been recently used successfully to treat cutaneous infantile hemangiomas, we decided to use it in three patients who presented with hepatic and skin hemangiomatosis. Three patients with skin and hepatic infantile hemangiomas, two of whom had evidence of cardiovascular compromise and one of whom had extensive liver involvement and hypothyroidism, were treated with oral propranolol. Regression of both skin and hepatic hemangiomas was noted in all patients, as was resolution of the cardiac symptoms and decreased thyroid requirement in two patients each. Propranolol was well tolerated without any adverse effects. Propranolol should be considered as a potential first-line therapy in patients with symptomatic hepatic hemangiomatosis.

© 2011 Wiley Periodicals, Inc.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Icon for Blackwell Publishing
    Loading ...
    Write to the Help Desk